AMPK activity exhibits a positive correlation with Bim levels and co-administration of metformin with Bcl-2/B-cell lymphoma-XL (Bcl-XL) inhibitors can promote the apoptosis of MYC-driven breast cancer cells [19]. Here, PRKAA1 is linked to breast cancer.